Showing results (421-430 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 26, 2020
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast CancerAngela R Bradbury, Linda Patrick-Miller, Brian L Egleston, et al.
JCO Precision Oncology|February 15, 2019
Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials ConsortiumMaria I Carlo, Veda N Giri, Channing J Paller, et al.
JCO Precision Oncology|February 15, 2019
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate CancerDeli Liu, Mandeep Takhar, Mohammed Alshalalfa, et al.
JCO Precision Oncology|January 29, 2019
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline ActionabilityNitya Raj, Ronak Shah, Zsofia Stadler, et al.
JCO Precision Oncology|January 16, 2018
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung CancerJustin F Gainor, Diane Tseng, Satoshi Yoda, et al.
JCO Precision Oncology|May 18, 2022
Tumor and Constitutional Sequencing for Neurofibromatosis Type 1Schuyler Tong, W Patrick Devine, Joseph T Shieh
JCO Precision Oncology|May 18, 2022
Clustered 8-Oxo-Guanine Mutations and Oncogenic Gene Fusions in Microsatellite-Unstable Colorectal CancerRussell W Madison, Xiaoju Hu, Vivek Ramanan, et al.
JCO Precision Oncology|July 23, 2021
Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-AnalysisPeey-Sei Kok, Won-Hee Yoon, Sally Lord, et al.
JCO Precision Oncology|May 11, 2022
Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal CancerHideaki Bando, Yoshiaki Nakamura, Hiroya Taniguchi, et al.
JCO Precision Oncology|June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based TherapyJeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Pageof 140